3. The presumption is that fair value can be measured reliably for a biological assert. That presumption can be rebutted, only at the time of initial recognition, for a biological asset for which market-determined prices or values are not available and for which alternative estimates of fair value are determined to be clearly unreliable. Once the fair value of such a biological asset becomes reliably measurable, it must be measured at its fair value less estimated costs to sell.